BSD Medical: Hyperthermia System For Cancer Treatment Installed At Lankenau Hospital
Salt Lake City, UT - BSD Medical Corporation recently reported that the Lankenau Hospital Department of Radiation Oncology has become the first hospital in the Philadelphia region and the 17th nationwide (in the past 24 months) to acquire the BSD-500 Hyperthermia System for use in the treatment of cancer. The addition of the system significantly adds to the multidisciplinary arsenal of cancer treatment options Lankenau provides to the Philadelphia and Main Line community.
The BSD hyperthermia system delivers precision-focused heat energy to tumors in the body. It is used in combination with radiation therapy to enhance treatment effects by making cancer cells more sensitive to radiation. Hyperthermia treatment is typically delivered twice per week prior to radiation treatments.
In Phase III clinical trials where hyperthermia therapy was combined with radiation therapy, hyperthermia improved complete response for recurrent breast, head and neck, melanoma, and other cancers from 23 to 68 percent. Hyperthermia combined with radiation therapy has also shown improved control rates for patients with advanced cervical cancer.
"We are confident that the addition of hyperthermia to our treatment options will provide significant potential benefits to many of our patients," says Dr. Marisa Weiss, Director of Breast Radiation Oncology and Breast Health Outreach at Lankenau Hospital and founder and president of BreastCancer.org.
"Main Line Health System treats approximately 3000 cancer patients annually with remarkable results, improving overall survival and quality of life," said Dr. Albert Denittis, Chief of Radiation Oncology. "We are pleased to be the first hospital in the region to offer this treatment modality to our patients."
"The Lankenau Radiation Oncology Department has been on the cutting-edge of technology in acquiring weapons to further expand our services in the fight against cancer and hyperthermia furthers this commitment to our patients," says Gary Antonelli, Radiation Oncology Administrator.
SOURCE: BSD Medical Corporation